ArticleJournal of neuroinflammation2022

Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis.

Celia Camacho-Toledano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.